An independent guide to cash-pay care. Every price is dated and sourced.

How we check
Wellchosen HealthSearch

Mindbloom review: at-home ketamine cost, safety and record

Mindbloom is a real telehealth company that prescribes compounded ketamine for use at home, priced at $1,290 for 6 sessions to $2,970 for 18 sessions for new clients, or $165 to $215 a session (checked Oct 25 2026) [1].

Bottom line: Rated Clean; good fit for an at-home ketamine program with guide sessions; $165 to $215 a session.

Updated By the Wellchosen Health editorial team

We rate it Clean under our rules: we found no FDA warning letter to Mindbloom [6] [7], no BBB Pattern of Complaints alert [9] and no regulator action or court finding. That is not a safety rating for at-home ketamine, which FDA warned about in 2023 [5], and a wrongful death lawsuit filed against the company in October 2025 makes allegations no court has ruled on; we found no ruling as of Oct 25 2026 [11].

Mindbloom is a US telehealth platform whose affiliated psychiatric practices prescribe compounded ketamine tablets or injections for depression, anxiety and PTSD, taken at home with guide support.

Our verdict

Clean

No FDA warning letter, BBB Pattern of Complaints alert, regulator action or court finding against Mindbloom, so it is Clean under our rating rules [6] [7] [9]. The treatment itself is compounded ketamine used off-label at home, which FDA has warned carries added risk [5].

What checks out

  • Publishes program prices: $1,290 for 6 sessions, $2,220 for 12 and $2,970 for 18 [1].
  • Full refund if a clinician decides treatment is not a medical fit [1].
  • Lists clear exclusions, such as psychosis, uncontrolled high blood pressure and pregnancy [2].
  • BBB grades it A, with no Pattern of Complaints alert [8] [9].

What to watch

  • Compounded ketamine is not FDA-approved for depression or anxiety [4] [5].
  • Pending wrongful death lawsuit filed in October 2025; its claims are allegations, not findings [11].
  • No insurance; a superbill is provided for possible reimbursement [1].
  • Pharmacy and individual clinicians not named on the pages we read [1] [2].
  • BBB customer reviews average 1 out of 5 from 30 reviews [10].
FDA record
No warning letter to Mindbloom found in an fda.gov search or a compilation of 163 letters through Sept 30 2026 [6] [7]. FDA's Oct 10 2023 alert on compounded and at-home ketamine is a general warning, not a letter to the company [5].
BBB
A, not accredited, as of Oct 25 2026. BBB's stated reason: "61 complaint(s) filed against business." Its complaint page shows 59 in 3 years and 7 in the last 12 months, with 48 answered, 10 resolved and 1 unresolved; customer reviews average 1 out of 5 from 30 [8] [9] [10].
Best for
Adults in one of its 38 states diagnosed with depression, anxiety or PTSD who have discussed ketamine with a clinician and want a structured at-home program with published prices.

See Mindbloom priceson the Mindbloom website

FDA status
Off-labelKetamine is approved as an anesthetic; Spravato is the approved esketamine spray [5] [14]
States
38 statesNot in AL, AK, AR, CT, ID, LA, MN, MS, NH, ND, OK, RI [3]
FDA letter
None foundFDA's 2023 ketamine alert is general, not a letter [5]
BBB
A ratingBBB reason: 61 complaints filed; 7 in the last 12 months [8] [9]

If you are in crisis

Call or text 988 to reach the 988 Suicide and Crisis Lifeline, or chat at 988lifeline.org. It is free, confidential and open 24/7 [16]. If you or someone else is in immediate danger, call 911.

What Mindbloom costs

Mindbloom sells programs, not single sessions. The price is the same for tablets and injections [1]. Here is what it listed for new clients on Oct 25 2026 [1].

Mindbloom prices for new clients
ProgramTotalPer sessionPayment planCheckedSource
6 sessions$1,290$215$430 a month for 3 monthsOct 25 2026[1]
12 sessions$2,220$185$370 a month for 6 monthsOct 25 2026[1]
18 sessions$2,970$165$330 a month for 9 monthsOct 25 2026[1]
The 6-session program includes 3 guide coaching sessions, 2 clinician consults, a kit Mindbloom calls the Bloombox, group integration circles and app access; longer programs add guide and clinician time [1]. Returning clients pay less, but the two returning-client price blocks on the page did not match each other when we checked [1].

Costs and terms to check

  • Insurance. Mindbloom does not accept insurance. After the first virtual visit it gives a superbill with billing codes you can send to your plan [1].
  • Refunds. If a clinician decides treatment is not appropriate, Mindbloom says you get a 100% refund [1].
  • HSA and FSA. Some services may qualify; Mindbloom says eligibility is set by your card's processor [1].
  • Returning-client prices. Ask which price applies before you buy, since the page showed two different sets [1].

For the full picture, including Spravato and IV clinics, see our ketamine therapy cost guide.

What Mindbloom prescribes, and its FDA status

Mindbloom's affiliated clinicians prescribe ketamine as tablets that dissolve under the tongue or as injections under the skin, both compounded by 503A pharmacies [2]. Mindbloom states that FDA has not determined that the compounded ketamine it prescribes is safe and effective, and that these products are not FDA-approved for anxiety, depression or other mental health conditions [4]. FDA puts it more bluntly: "Ketamine is not FDA approved for the treatment of any psychiatric disorder" [5]. Compounded drugs are not FDA-approved, and FDA does not check their safety, effectiveness or quality before they are sold [17].

The FDA-approved option in this drug family is Spravato, an esketamine nasal spray. It is available only through a restricted program, is given only in healthcare settings enrolled in that program (a REMS), and requires at least 2 hours of observation after each dose [14]. That is the main difference: Spravato is given under watch in a clinic, while Mindbloom's ketamine is taken at home.

Who Mindbloom says should not use it

Mindbloom requires clients to be 18 or older, live in or visit a state it serves, and be diagnosed with anxiety, depression or PTSD by its clinician [2]. It tells people not to proceed if they have a ketamine allergy, psychosis or mania symptoms, uncontrolled high blood pressure, heart failure or another serious heart problem, a severe breathing problem, raised eye or brain pressure, hyperthyroidism, another serious illness, or are pregnant, nursing or trying to conceive [2]. It says a peer treatment monitor must be physically present during treatment and that you should not drive after a session [4].

FDA's Oct 10 2023 alert on compounded and at-home ketamine

This is context, not a warning letter to Mindbloom. FDA warned patients and providers that compounded ketamine is not approved for any psychiatric disorder, that home use "presents additional risk" because no provider is on site, and that use without monitoring may lead to serious problems such as sedation and dissociation. Spravato has a REMS safety program; compounded ketamine does not. FDA described an April 2023 report of a patient whose breathing slowed after taking compounded oral ketamine outside a clinic, with a blood level about double that typically seen in anesthesia [5].

States, clinicians and pharmacy

  • States. Mindbloom says it is available in 38 states and also lists Washington, DC. It does not list Alabama, Alaska, Arkansas, Connecticut, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire, North Dakota, Oklahoma or Rhode Island [3].
  • Clinicians. Mindbloom, Inc. says it provides services to "affiliated psychiatric medical practices which are independently owned and operated," and that Mindbloom Medical Group, P.C. reviewed its website [2]. Each client gets a psychiatric clinician, a guide and a support team [2]. The pages we read did not name individual clinicians.
  • Pharmacy. Not named on its site; it says only that 503A pharmacies compound the medicine [2] [4]. A November 2025 filing in the lawsuit below added Optio Rx, an Illinois specialty pharmacy chain, as a defendant, alleging it compounded and shipped the drug [13].

FDA, BBB, lawsuit and complaint record

FDA. We found no warning letter to Mindbloom in an fda.gov search [6] or in a compilation of 163 telehealth and compounding letters through Sept 30 2026 [7]. It is not in our FDA warning letter tracker.

BBB. BBB grades Mindbloom of Orlando, Florida A and lists it as not accredited, in business since Oct 1 2019 [8]. BBB's stated reason for the grade is "61 complaint(s) filed against business" [8]. Its complaint page shows 59 complaints in the last 3 years and 7 in the last 12 months; 48 are marked answered, 10 resolved and 1 unresolved, with no Pattern of Complaints alert [9]. The most common types are service (18), product (17) and billing (10) [9]. BBB customer reviews average 1 out of 5 from 30 reviews [10]. Under our rating rules, a grade alone never sets a verdict.

Lawsuit. In October 2025 John Ward sued Mindbloom, a physician and a physician assistant in Pitt County, North Carolina, over the October 2023 death of his son Phillip Ward, 27, which the suit attributes to "ketamine toxicity in the presence of hypertension" [11]. These are allegations; none has been proven in court. The suit says missed appointments and other signs should have prompted a clinical review, and that his health history should have ruled out unsupervised home use [11]. Mindbloom founder and CEO Dylan Beynon said "The facts will bear out that Mindbloom provides the highest quality of clinical care" [12]. We found no ruling as of Oct 25 2026, so the case is pending as far as we can tell. A lawsuit that has not been decided is not a court finding, so it does not trigger Avoid under our rules, but we think anyone considering at-home ketamine should know about it.

Regulators and LegitScript. We found no FDA, DEA, state board or regulator action against Mindbloom in searches on Oct 25 2026. We could not read LegitScript's lookup for its website.

Who Mindbloom fits, and who should look elsewhere

  • Fits you if a clinician has diagnosed depression, anxiety or PTSD, you live in a state it serves, and you want a home program with set prices and guide sessions [1] [2] [3].
  • Look elsewhere if you want an FDA-approved treatment. Spravato is given in REMS-enrolled clinics with 2 hours of observation [14]; our ketamine cost guide covers its price and insurance rules.
  • Look elsewhere if you have any condition on Mindbloom's exclusion list, such as uncontrolled high blood pressure or a history of psychosis [2].
  • Look elsewhere if you cannot have a sober adult with you during each session, which Mindbloom requires [4].
  • Your own doctor or a private doctor can help coordinate care if you want someone outside the program.

Other at-home ketamine programs

Joyous, another telehealth company, prescribes compounded very low-dose ketamine lozenges off-label, with plans from $129 a month on a 3-month commitment or $159 a month without one, in 28 states [15]. We have not reviewed Joyous, so we do not link to it or rate it. If you are comparing programs, ask each one who the prescriber is, which pharmacy compounds the medicine, what monitoring it requires and what it charges in total.

Clinics that offer wellness drips such as NAD+ are a different service; see our wellness injections page. Some peptides, such as Selank, are sold for anxiety without FDA approval.

How we get paid

We may earn a commission if you sign up with a provider through a link on this page. That never changes a rating. Details: how we make money.

See Mindbloom priceson the Mindbloom website

Questions people ask

How much does Mindbloom cost?

For new clients, Mindbloom listed $1,290 for 6 sessions ($215 each), $2,220 for 12 ($185 each) and $2,970 for 18 ($165 each), checked Oct 25 2026 [1]. Tablets and injections cost the same [1].

Is Mindbloom legit?

Mindbloom is a real company, and we rate it Clean: we found no FDA warning letter to it [6] [7], BBB grades it A with no Pattern of Complaints alert [8] [9], and we found no regulator action or court finding as of Oct 25 2026. A wrongful death lawsuit filed in October 2025 is pending, and its claims are allegations, not court findings [11].

Does Mindbloom take insurance?

No. Mindbloom says it does not accept insurance, but after the first virtual visit it provides a superbill you can submit to your plan for possible reimbursement (checked Oct 25 2026) [1].

Is at-home ketamine FDA-approved?

No. FDA said on Oct 10 2023 that "Ketamine is not FDA approved for the treatment of any psychiatric disorder," and that home use of compounded ketamine adds risk because no provider is present [5]. Spravato, an esketamine nasal spray, is approved but given only in REMS-enrolled healthcare settings [14].

Did FDA send Mindbloom a warning letter?

We found none. An fda.gov search and a compilation of 163 letters through Sept 30 2026 show no warning letter to Mindbloom [6] [7]. FDA's Oct 10 2023 ketamine alert was a general warning to patients and providers [5].

What states is Mindbloom available in?

Mindbloom says it is available in 38 states plus Washington, DC, as of Oct 25 2026. It does not list Alabama, Alaska, Arkansas, Connecticut, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire, North Dakota, Oklahoma or Rhode Island [3].

What is the Mindbloom lawsuit about?

In October 2025 John Ward sued Mindbloom and two clinicians in Pitt County, North Carolina, over his son's October 2023 death, which the suit attributes to ketamine toxicity, and alleges missed warning signs [11]. These are allegations, not court findings. Mindbloom said the facts will show it gave high-quality care [12]. We found no ruling as of Oct 25 2026, so the case is pending.

Medical review: pending. A licensed clinician has not yet reviewed this page.

Sources

17 cited
  1. Mindbloom pricing. Mindbloom, Oct 25, 2026.
  2. Mindbloom home page. Mindbloom, Oct 25, 2026.
  3. At-home ketamine therapy by state. Mindbloom, Oct 25, 2026.
  4. Important safety information. Mindbloom, Oct 25, 2026.
  5. FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders. U.S. Food and Drug Administration, 2023-10-10 (accessed 2026-10-25).
  6. Warning letters database. U.S. Food and Drug Administration, Oct 25, 2026.
  7. FDA warning letters database (compilation of fda.gov letters). WeightLossRankings.org, 2026-09-30 (accessed 2026-10-25).
  8. Mindbloom BBB business profile. Better Business Bureau, Oct 25, 2026.
  9. Mindbloom BBB complaints. Better Business Bureau, Oct 25, 2026.
  10. Mindbloom BBB customer reviews. Better Business Bureau, Oct 25, 2026.
  11. Wrongful death lawsuit filed in ketamine overdose of Greenville man. WITN, 2025-10-22 (accessed 2026-10-25).
  12. Ketamine provider responds to lawsuit filed in death of Greenville man. WITN, 2025-10-24 (accessed 2026-10-25).
  13. Dad expands wrongful death claims in ketamine overdose suit. Law360, 2025-11-04 (accessed 2026-10-25).
  14. Spravato (esketamine) nasal spray prescribing information. DailyMed, National Library of Medicine, revised 2026-03 (accessed 2026-10-25).
  15. Joyous at-home ketamine. Joyous, Oct 25, 2026.
  16. 988 Suicide and Crisis Lifeline. 988 Lifeline, Oct 25, 2026.
  17. Compounding and the FDA: questions and answers. U.S. Food and Drug Administration, 2025-09-16 (accessed 2026-10-25).

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

See Mindbloom pricesWe may earn a commission